Abstract
Mortality related to acute kidney injury is high and can
exceed 50% with medications implicated in many cases.
Despite the concurrent use of diuretics, angiotensin
converting enzyme (ACE) inhibitors/angiotensin II
receptor blockers (ARBs) with NSAIDs (‘triple whammy’)
is commonly cited as a risk factor for acute kidney injury,
there is limited published research.
| Original language | English |
|---|---|
| Pages (from-to) | 72-73 |
| Number of pages | 2 |
| Journal | Journal of Pharmacy Practice and Research |
| Volume | 43 |
| Issue number | 1 |
| Publication status | Published - 2013 |